S&P 500 Futures
(0.17%) 5 336.50 points

Dow Jones Futures
(0.06%) 40 162 points

Nasdaq Futures
(0.28%) 18 687 points

Oil
(-0.45%) $79.70

Gas
(1.52%) $2.67

Gold
(0.62%) $2 432.50

Silver
(1.43%) $31.71

Platinum
(-0.86%) $1 080.60

USD/EUR
(0.09%) $0.921

USD/NOK
(0.06%) $10.68

USD/GBP
(0.07%) $0.788

USD/RUB
(-0.38%) $90.63

Realtime updates for Fennec Pharmaceuticals [FRX.TO]

Exchange: TSX Industry: Biotechnology

Last Updated17 May 2024 @ 15:27

25% discount on Stockinvest.us - Use code: Podcast

1.93% $ 9.51

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 15:27):

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients...

Stats
Today's Volume	750.00
Average Volume	961.00
Market Cap	259.83M
EPS	$0 ( 2024-05-14 )
Next earnings date	( $0 ) 2024-07-31
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	190.20
ATR14	$0.0550 (0.58%)

Fennec Pharmaceuticals Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Fennec Pharmaceuticals Financials

Annual	2023
Revenue:	$21.25M
Gross Profit:	$19.99M (94.08 %)
EPS:	$-0.600

FY	2023
Revenue:	$21.25M
Gross Profit:	$19.99M (94.08 %)
EPS:	$-0.600

FY	2022
Revenue:	$1.54M
Gross Profit:	$1.45M (94.40 %)
EPS:	$-0.910

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-0.670

Financial Reports:

No articles found.

Fennec Pharmaceuticals Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Fennec Pharmaceuticals

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.